These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32720067)

  • 41. Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
    Vos NS; Fagel ND; Amoroso G; Herrman JR; Patterson MS; Piers LH; van der Schaaf RJ; Slagboom T; Vink MA
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1691-1699. PubMed ID: 31126887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
    Mekonnen EA; Tekle WG; Desai SK; Hassan AE
    Interv Neuroradiol; 2023 Aug; 29(4):459-465. PubMed ID: 35331035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Hu P; Sun Y; Li CL; Jin R; Xie Q; Jiang XJ; Wu LP; Jiang JJ; Qiu XB; Cao Y; Ji G; Wang H; Yao ZH; Li B; Xia Y; Wang JA; Jiang J
    Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():988-995. PubMed ID: 33734575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial.
    Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; Sixt S; Brucks S; Beschorner U; Klumb CT; Thieme M;
    EuroIntervention; 2020 Apr; 15(18):e1633-e1640. PubMed ID: 31687933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.
    Elmariah S; Ansel GM; Brodmann M; Doros G; Fuller S; Gray WA; Pinto DS; Rosenfield KA; Mauri L
    Am Heart J; 2019 Mar; 209():88-96. PubMed ID: 30685679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and Efficacy of Paclitaxel-Eluting Balloon Angioplasty for Dysfunctional Hemodialysis Access: A randomized trial Comparing with Angioplasty Alone.
    Therasse E; Caty V; Gilbert P; Giroux MF; Perreault P; Bouchard L; Oliva VL; Lespérance J; Ethier J; Ouellet G; Francoeur M; Cournoyer S; Soulez G
    J Vasc Interv Radiol; 2021 Mar; 32(3):350-359.e2. PubMed ID: 33483226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of Balloon Angioplasty and Stenting for Symptomatic Intracranial Atherosclerotic Stenosis at a High Volume Center.
    Ueda T; Takada T; Usuki N; Takaishi S; Tokuyama Y; Tatsuno K; Hamada Y; Yoshie T
    Acta Neurochir Suppl; 2021; 132():63-67. PubMed ID: 33973030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
    Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
    J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
    [No Abstract]   [Full Text] [Related]  

  • 50. DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial.
    Mo D; Tong X; Li X; Qin C; Pan Y; Guan S; Miao Z
    Stroke Vasc Neurol; 2024 Jul; ():. PubMed ID: 39043584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study.
    Nguyen TN; Zaidat OO; Gupta R; Nogueira RG; Tariq N; Kalia JS; Norbash AM; Qureshi AI
    Stroke; 2011 Jan; 42(1):107-11. PubMed ID: 21071722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis.
    Xu H; Fu X; Yuan Y; Quan T; Wang Z; Han K; Liu G; Guan S
    Front Neurol; 2020; 11():774. PubMed ID: 32849227
    [No Abstract]   [Full Text] [Related]  

  • 54. Reewarm™ PTX drug-coated balloon in the treatment of femoropopliteal artery disease: A multi-center, randomized controlled trial in China.
    Ye W; Zhang X; Dai X; Huang X; Liu Z; Jiang M; Liu C
    Int J Cardiol; 2021 Mar; 326():164-169. PubMed ID: 33127414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.
    Xu B; Gao R; Wang J; Yang Y; Chen S; Liu B; Chen F; Li Z; Han Y; Fu G; Zhao Y; Ge J;
    JACC Cardiovasc Interv; 2014 Feb; 7(2):204-211. PubMed ID: 24556098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health Care Utilization Following Inpatient Femoropopliteal Revascularization With Drug-Coated Balloon Angioplasty: A Nationwide Cohort Analysis.
    Gurin MI; Beyer SE; Weinberg M; Parikh SA; Armstrong EJ; Albaghdadi MS; Aronow HD; Carroll BJ; Yeh R; Secemsky EA
    J Endovasc Ther; 2021 Apr; 28(2):246-254. PubMed ID: 33426984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World.
    Böhme T; Noory E; Beschorner U; Jacques B; Bürgelin K; Macharzina R; Gebauer E; Cheung F; Lechner P; Nührenberg T; Zeller T
    JACC Cardiovasc Interv; 2020 Sep; 13(17):2052-2061. PubMed ID: 32593696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.
    Kim JK; Ahn JY; Lee BH; Chung YS; Chung SS; Kim OJ; Kim WC; Joo JY
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):847-51. PubMed ID: 15145998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease.
    Qureshi AI; Suri MF; Siddiqui AM; Kim SH; Boulos AS; Ringer AJ; Lopes DK; Guterman LR; Hopkins LN
    J Neuroimaging; 2005 Jul; 15(3):240-9. PubMed ID: 15951406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.